SM

Steve Moore

Chief Operating Officer at Ossianix

Steve has spent the last 20 years in Pharma and Biotech both managing research organizations and research projects. Prior to joining Ossianix in 2012, he was site head at the Translational Medicine Research Collaboration laboratory in Dundee, Scotland. Prior to that, he managed GI biology research at Glaxo Smith Kline UK in the Neurology/GI CEDD and at Smith Kline Beecham Neuroscience he was a team leader in Neurodegeneration. Steve received his Ph.D. in Biochemistry from the Institute of Neurology, University of London and worked at Guys & St Thomas’s Medical School, as Principal Medical Laboratory Scientist in Experimental Pathology before joining industry.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Ossianix

OSSIANIX, INC is a privately held pre-clinical company that develops Biotherapeutic products using the highly versatile single domain VNAR antibody from the shark.


Industries

Employees

11-50

Links